CompaniesChiome Bioscience

Chiome Bioscience

active
Tokyo, Japan
Founded 2005
Website
About

Antibody Generation and out-licensing

Areas of Focus

Categories

Biologics & BiopharmaceuticalAntibodyJapan
Clinical Trials (2)
View all

Total Trials

2

As Lead Sponsor

2

As Collaborator

0

Total Enrollment

136

By Phase

PHASE1: 2

By Status

RECRUITING: 2

Recent Trials

NCT07016997Lead Sponsor
A Phase I, First in Human Study of CBA-1535, T Cell Engager(5T4/CD3/5T4) in Patients With Advanced Solid Tumors.
PHASE1Recruiting
70 participants
Started: Jun 27, 2022 · Completed: Dec 31, 2026
NCT06636435Lead Sponsor
A Phase I, First in Human Study of CBA-1205, Anti-DLK1 Monoclonal Antibody in Patients With Advanced Solid Tumors, Hepatocellular Carcinoma (HCC), Melanoma, and Pediatric Cancer
PHASE1Recruiting
66 participants
Started: Jun 1, 2020 · Completed: Jun 30, 2026
Locations (1)
Headquarters
Tokyo, Japan
Map

Loading map...

Chiome Bioscience | Biotech Hunter | Biotech Hunter